Palantir and Apple headline a busy Q3 2026 earnings wave with mixed market reactions

Palantir Technologies reported third-quarter 2026 revenue that nearly doubled year over year, surpassing $2 billion for the first time and beating Wall Street estimates, yet shares moved only marginally higher after hours. U.S. commercial revenue surged 148% to $984 million, topping U.S. government revenue of $953 million for the first time in the company's history. Palantir raised its full-year 2026 revenue guidance to $8.53 billion, reflecting 91% growth, and projected fourth-quarter revenue of roughly $2.65 billion.

Apple capped its fiscal year with a record September-quarter revenue of $114.5 billion, up 12% year over year, with iPhone hitting a September-quarter record and Services reaching an all-time high. Diluted earnings per share came in at $2.10, up 14%, including a $0.05 boost from tariff refunds.

Among the session's other notable movers, EverQuote posted record Q3 results with revenue up 25% to $218.1 million, driven by 70% growth in its home and renters insurance vertical, and its stock soared. Jazz Pharmaceuticals reported record quarterly revenue of $1.2 billion, up 10% year over year, fueled by 12% growth in Xywav, and raised its full-year 2026 revenue guidance. Ethos Technologies stood out with a 151% revenue jump in Q3. On the negative side, Waystar shares fell 7.4% following its results, Lightbridge's loss widened and its stock dropped 8.5%, Emergent BioSolutions missed Q3 estimates and shares fell, and Travere Therapeutics posted a revenue beat but shares declined nonetheless. Hinge Health impressed with 52% revenue growth and 33% operating margins, while Upwork topped estimates and its shares jumped on surging profitability.